StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

TEVA — Teva Pharmaceutical Industries Limited

EXPENSIVE (MOS -46.1%) · Quality 44/100

Price
43.08
Intrinsic value
29.49
Margin of safety
-46.1%
Implied growth (reverse DCF)
+18.6%
model assumes +11.7%
Value Score
0.1
Quality
44
Psychology
-18.9
Discovery
14.5
price/volume attention only
Moat score
70.5
erosion: none

Value Score: bottom 2% of Foreign US-listed · Quality: bottom 15%

Open the interactive Deep Dive for TEVA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/TEVA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is TEVA undervalued?

As of 2026-11-11, TEVA trades at 43.08 against a computed intrinsic value of 29.49 (-46.1% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Teva Pharmaceutical Industries Limited's Value Score?

Teva Pharmaceutical Industries Limited's Value Score is 0.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.